Professional Documents
Culture Documents
Ronak Thesis
Ronak Thesis
BY
GUIDE CO-GUIDE
May 2015
Date: / / 2015
I
Compliance Certificate
This is to certify that research work embodied in this thesis entitled “ STUDY OF
BIOMETHANATION PROCESS FOR PHARMACEUTICALWASTEWATER
USING UASB REACTOR ” was carried out by Mr. PATEL RONAK BIPINBHAI
(Enrollment no: 130080717007) at BVM Engineering College, Vallabh Vidhyanagar
(007) for partial fulfillment of Master of Engineering degree to be awarded by Gujarat
Technological University. He has complied to the comments given by the Dissertation
phase – I as well as Mid Semester Thesis Reviewer to my satisfaction.
Date: / / 2015
Place: Vallabh Vidyanagar
(Mrs. S. M. Patel)
III
Paper Publication Certificate
Date: / / 2015
Place: Vallabh Vidyanagar
IV
Declaration of Originality
I hereby certify that we are the sole authors of this thesis and that neither any part of this
thesis nor the entire of the thesis has been submitted for a degree to any other University
or Institution.
We certify that, to the best of our knowledge, the current thesis does not infringe upon anyone’s
copyright nor violate any proprietary rights and that any ideas, techniques, quotations or any
other material from the work of other people included in our thesis, published or
otherwise, are fully acknowledged in accordance with the standard referencing practices.
Moreover, to the extent that we have included copyrighted material that surpasses limit
of reasonable managing inside of the importance of the Indian Copyright (Amendment)
Act 2012, we ensure that we have obtained a written permission from the copyright
owner(s) to include such material(s) in the present theory and have included duplicates of
such copyright clearances to our appendix.
We declare that this is a true copy of thesis, including any final revisions, as approved by
thesis review committee.
We have checked review of the present thesis using anti-plagiarism database and it is in
allowable limit. Even though later on in case of any complaint pertaining of plagiarism, we are
sole responsible for the same and we comprehend that according to UGC standards, University
can even deny Master of Engineering degree presented to the understudy presenting this thesis.
Date: / / 2015
Place: Vallabh Vidyanagar
V
Thesis Approval Certificate
Technological University.
Date:
Place:
……………………. ..……………………
( ) ( )
VI
Dedicated to:
God and
My beloved parents
VII
ACKNOWLEDGEMENT
It is my privilege to express deep sense of gratitude to all those who have whole heartedly
helped, cooperated and encouraged me during the entire period of my dissertation work.
I express my deep sense of gratitude to my guide, Dr. Dipak S. Vyas (Professor, Civil
Engineering Department) who has continuously and enthusiastically guided and
encouraged throughout my research work. My work has taken this shape due to his
instructive and innovative ideas, suggestions and support.
I extend my heartfelt thanks to Mr. Haresh Joshi, MD and Mr. Mukesh Pathak, Quality
and Technical Manager Unistar Environmental & Research Laboratory PVT. LTD. , Vapi
for providing all the facilities and cooperation for my dissertation work.
I express sincere thanks to Dr. L. B. Zala (Head of the Civil Engineering Department)
and Dr. F. S. Umrigar (Principal of Birla Vishvakarma Mahavidalaya, Vallabh
Vidyanagar) for giving me an opportunity to undertake this work.
Last but not the least heartfelt thanks, to BVM Engineering College and its management
for giving me an opportunity to take up my course of study and research work in the field
of environmental engineering.
Date : / / 2015
(Ronak B. Patel)
VIII
. TABLE OF CONTENTS .
Page No.
TITLE
CERTIFICATE I
DECLARATION OF ORIGINALITY V
ACKNOWLEDGEMENT VII
TABLE OF CONTENTS IX
ABSTRACT XV
CHAPTER-1 INTRODUCTION
IX
1.4.1 Introduction 8
1.4.2 Manufacturing process Overview 8
1.4.3 Physical Methods 9
1.4.3.1 Formulation 9
1.4.3.2 Extraction 9
1.4.3.4 Antibiotics, vitamins and enzymes 9
1.4.4 Pharmaceutical Industry; waste and Standards 10
1.4.4.1 Wastewater Generation 10
1.4.4.2 Standards 12
1.4.5 Wastewater treatment system 12
1.4.5.1 Primary treatment 13
1.4.5.2 Secondary treatment 13
1.4.5.3 Tertiary treatment 14
3.2.1 Neutralization 32
3.2.2 Coagulation 32
3.2.3 Dosage 33
3.3.1 Hydrolysis 34
3.3.2 Acidogenesis 34
3.3.3 Acetogenesis 34
3.3.4 Methanogenesis 34
X
3.4 UASB controlling factors 35
3.4.1 pH 35
3.4.2 Mixing 35
3.4.3 Temperature 35
3.4.4 HRT 36
4.2.1 pH 52
4.2.2 Alkalinity 53
4.2.3 TSS and VSS 54
4.2.4 COD Removal (%) 56
XI
4.2.5 BOD and Gas Generation 59
4.2.6 Gas Generation 62
4.3 Discussions 63
CHAPTER-5 CONCLUSION 65
CHAPTER-6 FUTURE SCOPE OF WORK 67
REFERENCES 69
APPENDIX – I Abbreviation 74
APPENDIX – II Paper Publication Certificates 75
APPENDIX – III Plagiarism Report 76
APPENDIX – IV List of Industrial Visit 81
APPENDIX – VI Review Card 82
XII
. LIST OF FIGURES .
No. Title Page No.
1.1 Anaerobic Digestion Process 3
XIII
. LIST OF TABLES .
No. Title Page No.
1.1 Wastewater Generation from a Pharmaceutical 10
Formulation Unit
flow system
flow system
XIV
STUDY OF BIOMETHANATION PROCESS FOR PHARMACEUTICAL
WASTEWATER USING UASB REACTOR
Submitted by
PATEL RONAK BIPINBHAI
Supervised by
Dr. D. S. VYAS
ABSTRACT
Up flow anaerobic sludge blanket (UASB) reactor is widely used for the treatment of
different industry wastewater. In this study of a lab scale Up flow anaerobic sludge
blanket (UASB) reactor, treating an anti-biotic compound combination based
pharmaceutical wastewater was assessed under distinctive working conditions. A pipe
Column with a diameter of 152.4 mm and total height of 1050 mm with estimated
volume of 20 liters was utilized as a reactor. To make the medium ready and acclimatize
for efficient COD removal, the waste was recycled twice having each recycle of 5 days
with the culture medium of 30% volume, this was established by repeated experiments.
The loading rates on reactor were kept constant after recycling of wastewater two times.
The waste used in experiment was having a COD range of 61405 mg/L to 63105 mg/L.
The study was carried out for 30 days continuously during which the wastewater was
having temperature between 18 to 22º C. The ambient temperature was also around 20ºC,
as the season was winter.
With maximum retention time of 24 hours, the maximum COD removal was obtained as
67.8% with a gas generation of 0.24 m3/day.
Similarly maximum BOD reduction was found to be 67.28%. The TSS & VSS increase
from 164 mg/L & 136 mg/L to 2359 mg/L & 1958 mg/L respectively due to microbial
activity. The pH was found to decrease from 7.5 to 6.8 and the alkalinity reduced from
3555.4 mg/L to 11877.3 mg/L.
XV
Chapter 1
CHAPTER-1
INTRODUCTION
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 1
Chapter 1
We are at present living in the transition from a linear economy founded on abundant
fossil resources to a circular bio based economy concept , where waste and by products
should re-enter the cycle of production and the energy carried out from renewable
sources. In the circular economy's thinking, ideas in view of a mixture of bio resources,
by products and wastes are emerging. There is a huge opportunity for anaerobic digestion
as multi useful procedure that integrates environmental protection, renewable energy
production, nutrients and water reusing.
Fast industrialization has resulted in the generation of huge amount of wastes, both liquid
& solid, in industrial sectors such as sugar, pharmaceutical, paper & pulp, fruit & food
processing, distilleries, dairies, sago / starch, slaughterhouses, poultries, tanneries, and so
forth It has been evaluated that there is a potential for recuperation of around thousand
MW of energy from industrial wastewater. Despite requirements for pollution control
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 2
Chapter 1
measures, these wastes are generally dumped on land or discharged into water bodies,
without sufficient treatment, and thus become a large source of environmental pollution
and health hazard. This issue can be moderated through the appropriation of viable waste
management systems and waste to energy conversion technologies. [24]
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 3
Chapter 1
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 4
Chapter 1
Organic compounds
(Carbohydrates, proteins, lipids etc.)
Lipasae, protease, pectinase,
Cellulase, amylase produced by
Stage-1 Hydrolysis
hydrolytic microorganisms
β-oxidation, deamination,
Stage-2 Acidogenesis glycolysis, ring reduction
& ring cleavage
Short chain fatty acids
(Mainly formic & acetic acids)
Stage-3 Acitogenesis
CH4 + CO2
Figure 1.2 Metabolic course for the transformation of natural matter to the
methanogenic substrate (acetate, CO2 and H2) and finally to CH4 and CO2
[9]
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 5
Chapter 1
o Accordingly, it gives the thought that the microbial consortia acclimatized at low
temperature reaches, used by the greater part of the researchers for
biomethanation at psychrophilic temperature range are not true psychrophiles.
This has been derived by the way that true psychrophiles won't survive due at
expanded temperature. Most of the examination demonstrates increment in gas
creation with the increment in temperature. Subsequently, it can be gathered that
these are psychrotrophs (living creatures that can withstand warm fluctutions).
o It has been further watched that these microorganisms can develop at temperature
range as low as 1°C. These researchers have studied only the temperature profile
of the isolated micro flora.
o Detailed studies are obliged to determine the attributes of the psychrophiles and
mesophiles. Moreover, parametric studies on assessing an execution of these
psychrophiles in the biomethanation procedure need to be completed. [9]
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 6
Chapter 1
1. To study & develop an up flow anaerobic sludge blanket reactor (UASB) for a
pharmaceutical industry wastewater for reduction of COD.
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 7
Chapter 1
1.4.1 Introduction
Pharmaceutical and Drugs manufacturing industries play a key role in the Society as a
whole. The foundation of Modern Indian Pharmaceutical and Drugs Industries in the
establishment of Modern Indian Pharmaceutical and Drugs Industries in the nation was
laid in the first place of this century.. In 1901, the first processing plant M/s Bengal
Chemical & Pharmaceutical Works was set up in Calcutta. Hence the significant progress
in the industries have been made only after independence time. Today, India is one of the
leading country in manufacturing a larger quantity of diversified pharmaceutical
constitutes. The Pharmaceutical and Drugs assembling industry has come into the photo
as one of the main commercial enterprises in the nation. Around 82% of the aggregate
mass medications necessity is indigenously produced and the rest are imported. To
monitor outside trade and to energize indigenous creation the Government has forced
confinements on import of medications & crude materials. A few laws exist to manage
generation and appropriation of medications in the nation.
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 8
Chapter 1
procedures for individual drugs. The manufacturing processes are broadly classified and
described in the following sections.
1.4.3.1 Formulation
1.4.3.2 Extraction
1.4.3.3 Fermentation
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 9
Chapter 1
Raw materials like sugar, corn steep alcohol, starch, soya bean suppers, fish or whale
solubles thus on are used as crude materials. Vitamins & minerals are utilized as
development variables. The final items are frequently under 10% of the aggregate
arrangement. After detachment of the mycellium, the last item is recouped by distinctive
techniques like adsorption, filtration, molecule exchange, precipitation, decolonization,
center, vacuum drying etc. [14]
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 10
Chapter 1
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 11
Chapter 1
1.4.4.2 Standards
Parameter Concentration in (mg/L) except pH Parameter Concentration in (mg/L)
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 12
Chapter 1
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 13
Chapter 1
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 14
Chapter 2
CHAPTER-2
LITERATURE REVIEW
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 15
Chapter 2
K.R.Venkatesh et al, (2003) have been studied that the UASB process is known to be
energy conservative biotechnology. On account of minimal effort and low expertise
necessity render it to be a reasonable innovation for diminishing organic pollution loads.
Nonetheless, this system is confronting a test in the treatment of low quality wastewater
particularly vaccinated with non-granular sludge. This work was performed to emphasis
inside and out comprehension of a UASB reactor start up procedure inoculated with
processed slurry for treating synthetic wastewater of COD around 700 to 1000 mg/L. The
laboratory scale reactor with an effective volume of 9.97 L was worked under
encompassing temperature (24-350C). Toward the end of start-up period that went on for
84 days, this framework accomplished 90.8% COD reduction and a biogas creation of
4.72 L/d (457 L/ kg COD evacuation) at an OLR of 1.293 kg COD/ m3 d.
simultaneously, the VFA/ alkalinity proportion was found as 0.184. It confirms the
stability of the reactor. UASB reactor utilized in this study was manufactured utilizing
straightforward plexi glass container of 0.1 m measurement vertical tube shaped shape
with an aggregate volume of 11.78 L. The reactor basically had an inner viable working
volume of 9.97 L and the remaining volume of 1.81 L was kept for gas fluid strong
partition course of action. The overall height of the reactor was 1.5 m and effective height
being kept as 1.27m. The reactor had one influent port at the last, one profluent port and
five examining ports. The Gas Liquid Solid separator connected at the highest point of
the reactor was basically a situated of two altered cones with middle of the road cover to
encourage successful biogas gathering. Gas was gathered from the external transformed
cone and in addition underneath the dead corners of the internal cone. The treated
effluent gathered by a channel joined over the GLS separator was associated with a water
seal to keep the getaway of gas. A peristaltic pump was utilized for sustaining wastewater
as consistently as could be expected under the circumstances over the reactor base, goes
through the sludge bed in the reactor. The reactor was worked at mesophilic temperature
(24 to 35°C) [27]
D.R. Kashyap et al, (2003) have been studied that the digestion at psychrophilic
temperatures seems to have been finished by the mesophilic microorganisms acclimatized
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 16
Chapter 2
to psychrophilic temperatures, and there is a refinement in the writing concerning the use
of psychrophiles withdrew from forever frosty natural surroundings. Thus, it gives the
thought that the microbial consortia acclimatized at low temperature, used by most of the
investigators for biomethanation at psychrophilic temperatures are not true psychrophiles.
This has been inferred by the way that true psychrophiles won't get by at expanded
temperature. The vast majority of the exploration shows increment in gas creation with
the increment in temperature. Likewise, it can be accumulated that these are
psychrotrophs (organisms that can withstand thermal fluctuations). A portion of the
normal qualities indicated by that organisms during acclimatization procedure are
abatement in the quantity of ion pairs, the side chain commitment to the uncovered
surface and the apolar divisions of the uncovered surface, this may be the explanation
behind their brought down action at lower temperature. Consequently, it can be inferred
that investigation on the region of biomethanation in psychrophilic degree is in its start
and needs all around and sorted out studies. This domain has a considerable potential for
application in industrial, commercial and domestic sectors. [9]
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 17
Chapter 2
distinctive variables like cost, operation and support necessities, UASB and settled film
setups appear to be, all in all, to be the most suitable. [12]
E. Gasparikova et al, (2005) has been explored that an integrated system began from the
mix of aerobic and anaerobic advances was concentrated on. It can be said that the
properly worked two stage innovation is suitable for the evacuation of organic
contamination and suspended solids, while under perfect conditions even supplement
removal can be fulfilled. Energy decreased at around 25 to 40% appeared differently in
relation to the small wastewater treatment plants working on aerobic processes. The
operation of AS-ANA comb accepted the bringing down of the particular sludge
production by 40%. The repeated start-up of the WWTP is without bigger issues by
proper operation. The operation of AS-ANA comb demonstrated a few issues which
prompted a diminishing of treatment proficiency. This can be created by the gathering of
things that should not get into the WWTPs (oil, oil, cleaning agents, solvents,) by and
large. The variance of the wastewater stream can likewise be an irritating impact. The
operation of chosen AS-ANA comb WWTPs can be assessed absolutely. Most of the
chosen WWTPs were proficient in the removal of the organic pollution without expert
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 18
Chapter 2
operation, which is a standout amongst the most critical necessities for little treatment
plants. The results obtained from WWTP operation confirmed the viability of an
integrated anaerobic - aerobic system for municipal wastewater treatment, even in a
country with a temperate climate. [5]
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 19
Chapter 2
Mustafa Evren Ersahin et al, (2011) have been worked with the completely mixed
anaerobic digester. Anaerobic treatment is an energy producing procedure, in contrast to
aerobic systems that generally demand a high energy input for aeration purposes. It is an
actually straightforward and moderately modest innovation which consumes less energy,
space and creates less excess sludge in examination to the aerobic treatment technologies.
Energy generation from biogas makes the anaerobic treatment innovation an appealing
alternative over other treatment processes. The completely mixed anaerobic digester is
the basic anaerobic treatment system with an equal HRT and solids retention time in the
range of 15 to 40 days keeping in mind the end goal to give adequate retention time to
both operation and procedure stability. Completely mixed anaerobic digesters without
recycle are more suitable for wastes with high solids concentrations. Disadvantage of this
system is that a high volumetric loading rate is only obtained with quite concentrated
waste streams with a biodegradable chemical oxygen demand (COD) content between
8000 and 50000 mg/L. However, many waste streams are much dilute. Thus, COD
loading per unit volume may be very low with the detention times of this system which
eliminates the cost advantage of anaerobic treatment technology. Typical organic loading
rate (OLR) for completely mixed anaerobic digester is between 1-5 kg COD/m3.day. [4]
Takahashi M. et al, (2011) have been researched that the UASB reactor could maintain
stable treatment with a COD removal efficiency of 63 ± 13% and a UASB effluent of 118
± 40 mg/L in a temperature range of 10.6–27.7 °C at an HRT of 8 h. The UASB reactor
could maintain a high concentration of retained sludge (24.5 g/L), with a lower COD-
VSS loading rate of 0.05 gCOD/ gVSS/day, at which granular sludge could form from
the seeded mesophilic digester sludge. The richness of the retained sludge is understood
to contribute to stable COD removal efficiency in winter, with around three months at
temperatures below 15 °C. The VSS conversion rate and growth yield were clearly
evaluated as 0.029 gVSS/gCOD removed and 0.132 gVSS/gCOD, respectively, using
seasonal sludge profile estimation and daily water quality analyses. Longer SRTs, such as
the 293 ± 114 days shown during operation, seemed to contribute to not only retention of
bacterial sludge in the reactor but also temporary accumulation and resolution of difficult
to resolve materials such as cellulose. Proteobacteria, Bacteroidetes and Firmicutes were
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 20
Chapter 2
the dominant phyla of decomposers of solid organic matter in the library. The UASB
reactor accumulated low degradable solid substances such as cellulose, and it could
mineralize them by bacteria belonging to the Bacteroidetes and Firmicutes phyla. [23]
Toloti A. and Mehrdadi N. (2011) have been studied that the start-up time of an
anaerobic upflow anaerobic sludge blanket reactor is directly proportional to the
concentration of the microbial population. Rate of start-up relies on upon the type of
inoculums, the type & strength of waste, level of volatile acids maintained. Temperature
was measured daily in UASB reactor inlet and outlet with an electronic temperature
meter. The temperature was kept in mesophilic condition (30 to 35 oC) by controlling the
temperature of room, where the UASB reactor was kept in it. pH was measured daily in
reactors inlet and outlet with a pH meter probe and to control alkalinity of inlet, a sensor
was located in body of reactor that could realized decreasing the alkalinity and announce
to dosing pump and the pH of the reactor feed is constantly kept up impartial by include
vital measure of NaHCO3. The outlet pH is discovered to be in the range of 7-7.5
demonstrated a dynamic digestion system of the methanogens. The best operation of
anaerobic reactors can be normal when the pH is maintained near neutrality. Soluble
COD in the reactor influent and effluent was measured per day and the reactor was
operated at a continuous mode of operation. Also after experimental process analysis of
alkalinity, sludge volume index and COD were conducted in accordance with Standard
Method (SM, 1998). Best utilization of the reactor, respectively in organic loading rate of
10.81 kg COD/m3.day and HRT of 33.7 hr. Stable efficiency in this condition is 55.4 %
after 88 days. [25]
Powar M. M. et al, (2013) have been studied that Up-flow Anaerobic Sludge Blanket
(UASB) reactor is one of the anaerobic process. In this anaerobic treatment complex
organic matter is get converted into methane gas through the stages like hydrolysis,
acidogenesis and methanogenesis. UASB is widely applicable for treating various types
of wastewater. UASB has advantages over aerobic treatment. UASB reactor is feasible
for treating variety of wastewater. Performance of UASB reactor is get affected by pH,
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 21
Chapter 2
HRT, OLR, temperature and VFA to alkalinity ratio. Proper HRT should be provided to
give sufficient contact time between wastewater and bacteria. For avoiding VFA
accumulation in UASB reactor and for getting effective biogas production sodium
bicarbonate alkalinity should be provided. VFA to alkalinity ratio should maintained
between 0.5 - 0.8 for good performance of UASB reactor. [19]
Kumar R. and Snehlata (2013) have been studied that Pharmaceutical wastewater
contain a mixture of organic and inorganic compounds including spent solvents, added
substances, catalysts, reactants and little measures of intermediates & products, and may
subsequently be high in COD. The present study has been directed to assess the
productivity of UASB reactor for the treatment of pharmaceutical wastewater as far as
COD decrease under diverse feed concentration organic loading rate (OLR) and
hydraulic retention time (HRT). Execution of a lab scale up flow anaerobic sludge
blanket (UASB) reactor, treating pharmaceutical wastewater, was assessed under diverse
working conditions. Reactor was keep running in batch mode. After 10 weeks around
80% reduction in COD was observed. Which demonstrates that the reactor was properly
acclimatized. The reactor was worked in 3 stages with different OLR and HRT. The
UASB reactor was fed with different concentration of pharmaceutical effluent i.e. 10% of
wastewater at HRT of 24 hours and 20 hours and 50% of waste water at HRT of 20
hours. This study shows COD reduction of 97% , 91% and 89% in stage I, II and III
separately. Different parameters were likewise diminished in each of the three stages.
This normal reduction uncovers the correct working of the UASB reactor. The UASB
reactor is exceedingly proficient in the treatment of pharmaceutical wastewater and good
removal proficiency for COD at higher feed concentration of 50% dilution and it has
higher productivity for different OLR. [11]
Dr. R. Hema Krishna (2013) has been researched that the reactors used in wastewater
treatment for biohydrogen production (e.g. batch reactors, complete mix reactors, plug
flow reactors, bio-film reactors, suspended reactors, upflow anaerobic sludge blanket
reactor, anaerobic baffled reactors, upflow packed-bed attached growth reactors, attached
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 22
Chapter 2
growth fluidized bed reactors, anaerobic sequencing batch reactor, hybrid / high rate
reactors and membrane separation reactors. It is clear from the review that development
of these reactors can be considered a grown up research for which good design and scale-
up guidelines are available. A few reactors like Anaerobic Wastewater Treatment
Reactors receive great attention over the previous decades because of their various
benefits, for example, low energy utilization, low sludge generation, low chemical
consumption, vast potential of resource recovery, less equipment required and high
operational simplicity. On the other hand, conventional anaerobic systems are found to
have operational limits as far as long HRT, space prerequisite and facilities to capture
biogas. The uses of recently developed high rate reactors address these limits and give
expanded organic matter removal at shorter HRT and higher methane yields for biogas
generation. The majority of the incorporated reactors reported in this work need
substantial scale execution inside of industry and further work is required to assess the
execution of these promising reactors on a larger scale. Moreover, further changes, for
example, establishment of biogas capture system and usage of suspended carrier or
packing medium are considered essential. [6]
Narsimha Rao. P et al. (2014) have worked on the treatment of Pharmaceutical Industry
Wastewater by Using upflow anaerobic sludge blanket reactor. They have worked on the
execution of a lab-scale UASB reactor, treating an anti-microbial substance union based
pharmaceutical wastewater, was assessed under diverse working conditions. A pipe with
a breadth of 250 mm and aggregate tallness of 1.20 m and successful height of 1 m with
rough volume of 50 liter was utilized as a reactor. The loading rates on reactor were
expanded in ventures to evaluate the greatest loading limit of the reactor to study the
execution of reactor at diverse loading rates. The COD fixations utilized as a part of the
present examination ranges between 10,050 mg/L to 15,170 mg/L. The execution of the
reactor up to 10.81 kg COD/m3.d was assessed and the HRTs were inspected. During this
study, which went on for 120 days, the temperature of the wastewater entering the reactor
range from 30 - 35 o C and no heat exchanger was utilized. At long last the removal
proportion of COD with HRT of 33.7 hours and organic loading rate of 10.81 kg
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 23
Chapter 2
COD/m3.day were 54% respectively. The UASB reactor could be used as an effective
pre-treatment alternative for treatment of pharmaceutical wastewater, The efficiency of
the pilot has been gradually rising through course of time, Due to the nature of
wastewater, they preferred to add light nutrient such as sugar solution and reduction of
alkalinity can lead to lower efficiency of reactor. [15]
Rajender Singh Rana et al. (2014) have studied on the characterization and
bioremediation of pharmaceutical industries’ wastewater. Biological treatments methods
have traditionally been used for the management of pharmaceutical wastewaters. They
are subdivided into aerobic and anaerobic processes which include the use of activated
sludge, membrane batch reactor, sequence batch reactor, anaerobic sludge reactors,
anaerobic film reactors and anaerobic filters. The wastewater characteristics play a key
role in the selection of biological treatments. However, hydraulic retention time (HRT),
temperature, pH, dissolved oxygen (DO), organic load, microbial community, presence
of toxic and recalcitrant substances and the batch operation of the pharmaceutical
production are the few variables that require modifications for adaptation to
pharmaceutical wastewater to enhance the efficiency of the biodegradability and
mineralization capability of biological processes. Thus, bioremediation processes are
technological tools that hold great promise for the future. They produce almost no waste
by-product, have the potential of being cheaper and in combination with the different
physicochemical and advanced oxidation processes, offer a better treatment of
pharmaceutical industrial wastewater and thus help in utilizing the available water
resource in a sustainable manner. It is likely to become one of the best technologies used
to clean up and protect our environment. [20]
Kaviyarasan K. (2014) has been studied that the performance of UASB (Upflow
Anaerobic Sludge Blanket) reactor for treating various industrial and domestic
wastewaters at various operating conditions. The reactors can be used conveniently for
the treatment of tannery, distillery, food processing, metal mining, dairy, domestic
wastewater etc. The performance of the reactor mainly depends on the OLR and HRT.
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 24
Chapter 2
The author highlighted to enhance the start-up and granulation in UASB reactors, biogas
(methane and biohydrogen) production, coupling with post-treatment and the reactors to
overcome the temperature constraint and pH, improving the removal efficiencies of the
organic matter, nutrients and pathogens in the final effluent. UASB reactors are highly
efficient to remove organic pollutants like BOD, COD, and SS etc. These reactors can be
operated at both mesophilic and thermophilic conditions. The UASB system can solve
the environmental problems economically. The models and kinetics of the existing
UASB reactors can be used to improve the performance of reactor design, biomass
concentration, treating the heavy metals and biogas production. Compare to other
conventional methods, the cost involved in construction and maintenance is low. No costs
arise other than desludging costs and the operation of feeding pump. [10]
Zhiqiang Chen et al(2011) investigated that A full-scale test was conducted with an up-
flow anaerobic sludge blanket (UASB) pre-treating pharmaceutical wastewater The aim
of the study was to investigate the performance of UASB in the condition of a high
chemical oxygen demand (COD) loading rate from 12.57 to 21.02 kgm−3 d−1 and a wide
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 25
Chapter 2
pH from 5.57 to 8.26, in order to provide a reference for treating the similar chemical
synthetic pharmaceutical wastewater. A UASB reactor system was exhibited on a full
scale for the pretreatment of pharmaceutical wastewater containing high COD
fluctuating every day from 4726 - 19,951mg/L, from 143 - 315mg/L and 61 - 171mg/L,
individually, and with an extensive variety of pH from 5.57 - 8.26. Moreover the system
keeps running at a high COD loading rate from 12.57 - 21.02 kg/m3. d. The effluent
testing demonstrate that the UASB accomplished 39–85% COD removal rate, pH kept at
a narrow range of 7.18–7.72 however influent value was sharpy changed, demonstrating
that the UASB system performed well in pre-treat pharmaceutical wastewater under a
high COD loading rate (12.57–21.02 kg/m3.d), sharply fluctuation of pH (5.57–8.26),
and high COD influent concentration (4726–19,951 mg/L). [30]
Oktem Y. et al,(2007) studied that execution of a lab scale hUASB reactor, treating a
chemical synthesis based pharmaceutical wastewater, was assessed under different
operating conditions. This study comprised of two trial stages: first is acclimation to the
pharmaceutical wastewater and second is determination of maximum loading capacity of
the hUASB reactor. At first, the carbon source in the reactor feed came completely from
glucose, applied at an organic loading rate (OLR) 1 kg COD/m3.d. The OLR was slowly
step expanded to 3 kg COD/m3. d and soon thereafter the feed to the hUASB reactor was
dynamically changed by presenting the pharmaceutical wastewater in mixes with
glucose, so that the wastewater contributed more or less 10%, 30%, 70%, & 100% of the
carbon (COD) to be treated. At the acclimation OLR of 3 kg COD/m3. d the HRT was 2
days. During this time of feed modification, the COD removal efficiencies of the
anaerobic reactor were 99%, 96%, 91% & 85%, and particular methanogenic activities
were measured as 240, 230, 205 & 231 ml CH4/g TVS d, separately. Taking after the
acclimation period, the hUASB reactor was fed with 100% (w/v) pharmaceutical
wastewater up to an OLR of 9 kg COD/m3. d in order to determine the maximum loading
capacity achievable before reactor disappointment. At this OLR, the COD removal
proficiency was 28%, and the SMA was measured as 170 ml CH4/g TVS d. The hUASB
reactor was discovered to be much more successful at an OLR of 8 kg COD/ m 3.d with a
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 26
Chapter 2
COD removal effectiveness of 72%. As of right now, SMA value was 200 ml CH4/g TVS
d. It was concluded that the hUASB reactor could be a suitable option for the treatment of
chemical synthesis based pharmaceutical wastewater. [16]
Sreekanth D. et al, (2009) studied that The hybrid up flow anaerobic sludge blanket
reactor was evaluated for efficacy in reduction of chemical oxygen demand (COD) and
biochemical oxygen demand (BOD) of bulk drug pharmaceutical wastewater under
different operational conditions. The start-up of the reactor feed came entirely with
glucose, applied at an organic loading rate (OLR) 1 kg COD/m3.d. Then the reactor was
studied at different OLRs ranging from 2 to 11 kg COD/m3.d with pharmaceutical
wastewater. The optimum OLR was found to be 9 kg COD/m3.d, where they discovered
65 to 75% COD and 80 to 94% of BOD reduction with biogas generation containing 60
to 70% of methane and particular methanogenic action was 320 ml CH4/g-VSS d. From
the outcomes that were reasoned that the anaerobic hybrid UASB reactor is an
appropriate option for the treatment of pharmaceutical wastewater with high organic
concentration under thermophilic conditions. It gives effective organic removal
efficiencies, notwithstanding when worked at high organic loading rate and under
discontinuous operation. Moreover, under stressed operating conditions, such as organic
overloads, the reactor shows quite stable performance. Effective execution of the reactor
up to an OLR of 9 kg COD m3.d is illustrated, where 65 to 75% COD and 80 to 90% of
BOD reduction was observed. Biogas production is found to be close to the theoretical
value and high COD and BOD reduction could be achieved keeping the pH constant [21]
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 27
Chapter 2
propionic and n-butyric acids were found to be predominant volatile fatty acids in the
acidogenic reactor. Based on the results, an HRT of 12 h, pH of 5.5 ± 0.1 and OLR of 13
kg COD/m3.d were found to be the best combination of conditions, within the ranges
studied, for efficient acidification of a chemical synthesis based pharmaceutical
wastewater. Under these conditions, a maximum acidogenic conversion of 44% of the
influent soluble COD was achieved. Throughout the investigation, COD removal was in a
range of 10 to 25% and the main VFA were found to be acetic, propionic and n-butyric
acids. Acetic acid was produced in higher concentrations than other VFA in the
acidogenic reactor at all HRT and pH ranges investigated. HRT had only a minor effect
on the composition of VFA produced. however, VFA distribution was found to be highly
sensitive to the operating pH within the reactor. [17]
Chen Zhu et al(2014) studied on the execution of an UASB reactor was explored in the
treatment of diluted pharmaceutical wastewater for a continuous operation of 140 days.
Increment of the OLR from 2.7 kg COD/m3 d to 7.2 COD/m3.d prompted an increment in
the COD removal productivity from 83% to 91%. During the start-up, the HRT was 38.5
h and the OLR was about 2.8 kg/m3 d. The COD removal efficiency and biogas yield
were relatively low at first, but both increased gradually. At the end of this stage, the
removal efficiency maintained at 83% with slight fluctuations, and the biogas yield
reached about 0.43 L/g COD removed. [2]
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 28
3
CHAPTER-3
MATERIALS AND
METHODS
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 29
3
SR
Parameter Method Specification Method Name Permissible Limit unit Result
No
Standard Method by
1 pH APHA Ed.22nd Glass electrode 5.5-9 - 11.55
.2012,4500 - H+B
Standard Method by
Ammonical Preliminary
2 APHA Ed.22nd 50 mg/L 138.5
Nitrogen Distillation
.2012,4500 - NH3 –B
Standard Method by
5-Day BOD
3 BOD APHA Ed.20th 30 mg/L 18328
test
.1998,5210 – B
Standard Method by
4 COD APHA Ed.22nd Open Reflux 250 mg/L 54821.4
.2012,5220 – B
Standard Method by
Chloride as
5 APHA Ed.22nd Argentometric 1000 mg/L 488.9
Cl-
.2012,4500 – Cl
Standard Method by Distillation
Cyanide as
6 APHA Ed.22nd Followed by 0.2 mg/L N.A.
CN
.2012,4500 – CN Titrimetric
Standard Method by Partition-
Oil &
7 APHA Ed.20th Gravimetric 10 mg/L 8.1
Grease
.1998,5520 – B Method
Standard Method by Distillation
Phenolic
8 APHA Ed.22nd Followed by 1 mg/L 1.4
Compound
.2012,5530 - H+B Colorimetric
Sulphate
9 IS 3025 (Part 24) 1986 Turbidimetric 1000 mg/L 70
SO4-
Standard Method by
Sulphide as
10 APHA Ed.22nd Titrimetric 2 mg/L 33312.5
S
.2012,4500 - S2 F
Total Standard Method by
Gravimetric
11 Dissolved APHA Ed.22nd 2100 mg/L 1992
Method
Solid .2012,2540 – C
Total Standard Method by
Gravimetric
12 Suspended APHA Ed.22nd 100 mg/L 2
Method
Solid .2012,4500 – D
The effluent was collected from a Pharma Industry Named Megafine Pharma, Vapi,
Gujarat, India. The industry is it’s of its kind in India for the manufacture of pharma
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 30
3
based products and pharma intermediates. The effluent collected was stored at 4°C
under controlled conditions to prevent biodegradation. The salient physico-chemical
characteristics of the pharma effluent samples were determined based on standard
methods for examination of water and wastewater, 20th edition (APHA, 1998). The
effluent is found to be alkali and found to have a very high initial concentration of
COD. It is assessed that the chosen effluent is amenable for suitable digestion.
Lump,
Dolomitic quick 55-58
(Cao)0.6(MgO)0.4 49.8 24.8 Pebble,
lime Cao
ground
Powder,
Sodium bicarbonate NaHCO3 84 84 99
Granular
Sodium Hydroxide NaOH 40 40 Liquid 98
Chemical used to lower pH
Carbonic Acid H2CO3 62 31 Gas 27.9,31.4
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 31
3
3.2.1 Neutralization
3.2.2 Coagulation
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 32
3
when chemicals are added to adjust the pH of the wastewater to optimize the
performance of hydrolysed metal ions used as coagulants.
Polyelectrolytes may be divided into two categories: synthetic and natural. Synthetic
polyelectrolytes consist of simple nanomer that are polymerized into high molecular
weight substances depending on whether their charge when placed in water, is
negative, positive or neutral. Important natural polyelectrolytes include polymers of
biological origin and those derived from starch products such as cellulose derivatives
and alginares. These polyelectrolytes are classified as cationic, anionic, and non-
ionic, respectively.[13]
3.2.3 Dosage
Table 3.3 Dosage given to waste for treatment
1 pH 8.20
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 33
3
UASB process
Mainly in there are four key biological and chemical stages in UASB process i.e.
Hydrolysis, Acidogenesis, Acetogenesis and Methanogenesis.
3.3.1 Hydrolysis
Mostly organic concentration of wastewater is complex in nature. For the bacteria in
anaerobic digesters to access the energy potential of the material, these complex
organic constituents should break down into their smaller constituent parts. These
constituent parts, or monomers, such as sugars, are readily available to other bacteria.
The process of breaking these chains and dissolving the smaller molecules into
solution is called hydrolysis. Through hydrolysis the complex organic molecules are
broken down into simple sugars, amino acids, and fatty acids. Acetate and hydrogen
produced in the first stages can be used directly by methanogens. Other molecules,
such as volatile fatty acids with a chain length greater than that of acetate must first be
catabolised into compounds that can be directly used by methanogens.
3.3.2 Acidogenesis
The biological process of acidogenesis results in further breakdown of the remaining
components by acidogenic (fermentative) bacteria. Here, vfas are created, along with
ammonia, carbon dioxide, and hydrogen sulphide, as well as other by-products.
3.3.3 Acetogenesis
The 3rd stage is acetogenesis. Here, simple molecules created through the
acidogenesis phase are further digested by acetogens to produce largely acetic acid, as
well as CO2 and H2.
3.3.4 Methanogenesis
The terminal phase of anaerobic processing is the biological procedure of
methanogenesis. Here, methanogens utilize the moderate results of the preceding
stages and convert them into CH4, CO2, and H2O. These components make up the
majority of the biogas radiated from the system. Methanogenesis is sensitive to both
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 34
3
high and low pH and occurs between pH 6.5 & pH 8. The remaining, indigestible
material the microbes cannot use and any dead bacterial remains constitute the
digested. A simplified generic chemical equation for the overall processes outlined
above is as follows:
C6H12O6 → 3CO2 + 3C [19]
3.4.1 pH
The pH value is essentially influenced the UASB reactor performance and stability.
pH for this treatment is between the range of 6.3 to 7.8. The change in pH of influent
is principally a vital component for system stability. Raising the pH by adding NaOH
is likewise done to build the pH up to 7.4 to obtain increasing in the gas generation,
with decreasing in CO2 production.
3.4.2 Mixing
Good mixing between biomass and substrates is basically attributed by mixing
process. Mixing gives more opportunities of attachment by recycling biomass as well
as activating dead zones in sludge bed which is essentially restrained the phenomenon
of channelling Mixing can be accomplished through mechanical mixing, biomass
recirculation, or slurry recirculation. Rapid mixing is considered undesirable mixing
showing that it causes a biomass. [19]
3.4.3 Temperature
The efficiency of the anaerobic process is highly dependent on reactor temperature.
The rate of degradation of organics is enhanced at mesophilic temperatures. The
mesophilic temperature varies between 30 to 40ºC. However, the effect of
temperature is mainly governed by various physical, chemical, and biological
processes taking place in the reactor. A sharp drop in methane generation appears as
the reactor temperature exceeds 45ºC because of bacterial decay at higher
temperatures ranging from 45 to 65ºC. The effect of temperature on the efficiency of
the anaerobic process is governed by the reactor type as well. A decline in UASB
efficiency at low temperature can be explained due to decreases in biological activity.
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 35
3
3.4.4 HRT
The hydraulic retention time is significantly considered as the key operating
parameter where its effectiveness is mainly controlling the performance of UASB
reactor. The HRT is defined as the amount of time for which the wastewater is
retained in the reactor for digestion and is computed by dividing the volume of the
reactor by the influent flow rate. The UASB reactor gives high COD removal
efficiency at very short HRT. However, it is a function of effluent characteristics,
which vary from industry to industry. [28]
Size of Reactor: Generally, UASBs are considered where temperature in the reactors
will be above 20°C. At equilibrium condition, sludge withdrawn has to be equal to
sludge produced every day. The sludge produced daily depends on the characteristics
of the raw wastewater since it is the sum total of i) the new VSS produced as a
consequence of BOD removal, the yield coefficient being assumed as 0.1 g VSS/ g
BOD removed, ii) the non-degradable residue of the VSS coming in the inflow
assuming 40% of the VSS are degraded and residue is 60%, and iii) Ash received in
the inflow, namely TSS-VSS mg/L. Thus, at steady state conditions,
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 36
3
The reactor volume must be chosen that the desired SRT value is achieved. This is
done by explaining for HRT from SRT equation assuming (i) depth of reactor (ii) the
effective depth of the sludge blanket, and (iii) the average concentration of sludge in
the blanket (70 kg/m3). The full depth of the reactor for treating low BOD municipal
sewage is often 4.5 - 5.0 m of which the sludge blanket itself may be 2.0 - 2.5 m
depth. For high BOD wastes, the depth of both the sludge blanket and the reactor may
have to be increased so that the organic loading on solids may be kept within the
prescribed range. Once the size of the reactor is fixed, the up flow velocity can be
determined from
Up-flow velocity m/h = Reactor height
HRT, h
Using average flow rate one gets the average HRT while the peak flow rate gives the
minimum HRT at which minimum exposure to treatment occurs. In order to retain
any flocculent sludge in reactor at all times, experience has shown that the up-flow
velocity should not be more than 0.5 m/h at average flow and not more than 1.2 m/h
at peak flow. At higher velocities, carryover of solids might occur and effluent quality
may be disintegrated. The feed inlet system is next designed so that the required
length and width of the UASB reactor are determined.
The settling compartment is shaped by the sloping hoods for gas collection. The depth
of the compartment is 2.0 to 2.5 m and the surface overflow rate kept at 20 - 28
m3/m2.day (1 - 1.2 m/h) at peak flow. The flow velocity through the aperture
connecting the reaction zone with the settling compartment is constrained to not more
than 5 m/h at peak flow. Due attention has to be paid to the geometry of the unit and
to its hydraulics to ensure proper working of the "Gas-Liquid-Solid-Separator (GLSS)
the gas collection hood, the incoming flow distribution to get spatial uniformity and
the outflowing effluent. [3]
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 37
3
A single module can deal with 10 to 15 MLD of sewage. For large flows a number of
modules could be given. Some physical details of a typical UASB reactor module are
given below.[3]
Table 3.5 Physical parameter for UASB
Reactor Rectangular or circular. Rectangular shape is favoured
configuration
Width or diameter To limit lengths of inlet laterals to around 10-12 m for
encouraging uniform flow distribution and sludge
withdrawal.
Depth 4.5 - 5.0 m for sewage.
Inlet feed gravity feed from top (favoured for municipal sewage) or
pumped feed from bottom through manifold and laterals
(favoured in case of soluble industrial wastewaters).
Length As necessary.
Deflector/GLSS This is a deflector beam which together with the gas hood
(slope of 60) forms a "gas-liquid-solid-separator" (GLSS)
releasing the gas goes to the gas collection channel at top,
while the liquid rises into the settler compartment and the
sludge solids fall back into the sludge compartment. The
flow velocity through the aperture connecting the reaction
zone with the settling compartment is generally limited to
about 5 m/h at peak flow.
Settler compartment 2.0 - 2.5 m in depth. Surface overflow rate equals 20 - 28
m3/m2/d at peak flow.
Sludge blanket depth 2 - 2.5 m for sewage. More depth is needed for stronger
wastes.
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 38
3
A few process design parameters for UASBs are listed below for municipal sewages
with BOD around 200 to 300 mg/L and temperatures above 20°C. [7]
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 39
3
It is very important to examine the microorganism used in the reactor some method
used for this are explained below.[20]
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 40
3
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 41
3
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 42
3
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 43
3
different zones viz., sludge bed zone, sludge blanket zone and settling zone. The
influent tank was given of 20 litres. This outlet was joined through a silicon tube to a
wet gas meter. The physical dimensions of the lab model of UASB reactors are given
in Table.
Table 3.7 Physical dimensions of the laboratory model of UASB
Sr. No. Physical Parameter Size
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 44
3
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 45
3
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 46
3
It can be noted that one of the principal concerns in wastewater treatment is the
removal of substrate. Stated another way, the goal in bio logical wastewater
treatment is, in most cases, to deplete the electron donor (i.e., organic
compounds in aerobic oxidation). For heterotrophic bacteria the electron donors are
the organic substances being degraded; for autotrophic nitrifying microbes it is
ammonia or nitrite or other reduced inorganic compound. The substrate utilization
rate in biological systems is modelled with the following expression for soluble
substrates. Because the mass of substrate is decreasing with time due with substrate
utilization and Equation i s u s e d in substrate mass balances, a negative value is
shown.
rsu = - k.X.S
Ks+ S
Where rsu = rate of substrate concentration change due to utilization , g/m3.d
X = biomass(microorganism) concentration , g/m3
S = growth limiting substrate concentration in solution , g/m3
k = maximum specific substrate utilization rate , g substrate / g
microorganisms. d
[13]
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 47
Chapter 4
CHAPTER-4
RESULTS AND
DISCUSSION
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 48
Chapter 4
In this chapter, results and discussion on the experimental data obtained from UASB
reactors based on continuous mode of operation is presented. The performance of the
reactor has been evaluated. Non-linear regression relationship for the performance of the
reactor in terms of the significant parameters which influence the COD removal
efficiency have been obtained and discussed.
As per given in the table the results were obtained using different medium and types of
them. In low concentration culture the results are observed negative and in low volume
all the results are positive. These results are given in image below.
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 49
Chapter 4
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 50
Chapter 4
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 51
Chapter 4
4.2.1 pH
pH values gently increase with decrease in time of operation and found to be in the range
of 7.89- 6.7 is shown in graph given below
8 8
7.8 7.5
7.6
7
pH
pH
7.4
6.5
7.2
7 6
0 2 4 6 0 2 4 6
Day Day
8 8
7.5 7.5
7 7
pH
pH
6.5 6.5
6 6
0 5 10 10 15 20
Day Day
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 52
Chapter 4
4.2.2 Alkalinity
Alkalinity concentration is decreases with time in 1st & 2nd recycling but there is variation
in continuous flow system. The values are in range of 12901.8-35555.4 which is shown
in the graphs given below.
40000.0
30000.0
Alakalinity
20000.0
1st Recycle
2nd Recycle
10000.0
0.0
0 1 2 3 4 5 6
Day
16000.0 16000.0
15000.0
15000.0
Alkalinity
Alkalinity
14000.0
14000.0
13000.0
13000.0
12000.0
12000.0 11000.0
0 5 10 10 15 20
Day Day
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 53
Chapter 4
2500
2000
1500
TSS, VSS
TSS
1000
VSS
500
0
0 1 2 3 4 5 6
Day
1st recycle
2500
2000
1500
TSS, VSS
TSS
1000
VSS
500
0
0 1 2 3 4 5 6
Day
2nd recycle
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 54
Chapter 4
2500
2000
1500
TSS, VSS
TSS
1000
VSS
500
0
0 2 4 6 8 10 12
Day
Continuous flow
2500
2000
1500
TSS, VSS
TSS
1000
VSS
500
0
10 12 14 16 18 20 22
Day
Continuous flow
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 55
Chapter 4
Inlet
Sr Waste Outlet % COD Kg COD
Date Days COD
No Supply COD(mg/L) Removal Removal
(mg/L)
1 24-01-2015 1 61405.3 58512 4.7 0.011
2 25-01-2015 2 61405.3 48120 21.6 0.051
1st
3 26-01-2015 3 61405.3 37535.2 38.9 0.092
Recycle
4 27-01-2015 4 61405.3 31232 49.1 0.116
5 28-01-2015 5 61405.3 27379.2 55.4 0.131
6 29-01-2015 1 61405.3 56600 7.8 0.018
7 30-01-2015 2 61405.3 47838.3 22.1 0.052
2nd
8 31-01-2015 3 61405.3 36954.1 39.8 0.094
recycle
9 01-02-2015 4 61405.3 26366 57.1 0.135
10 02-02-2015 5 61405.3 21232 65.4 0.154
Inlet
Sr Waste Outlet % COD Kg COD
Date Days COD
No Supply COD(mg/L) Removal Removal
(mg/L)
1 03-02-2015 1 62452 21536 65.5 0.157
2 04-02-2015 2 62414 20832.6 66.6 0.160
3 05-02-2015 3 61962 21735 64.9 0.154
4 06-02-2015 4 62126 23212 62.6 0.149
5 Continuous 07-02-2015 5 62154 21314.8 65.7 0.157
6 Flow 08-02-2015 6 61875 22925 62.9 0.150
7 09-02-2015 7 61579 24516.1 60.2 0.142
8 10-02-2015 8 61325 21637 64.7 0.152
9 11-02-2015 9 60248 22427 62.8 0.145
10 12-02-2015 10 60486 20525 66.1 0.153
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 56
Chapter 4
Inlet
Sr Waste Outlet % COD Kg COD
Date Days COD
No Supply COD(mg/L) Removal Removal
(mg/L)
1 13-02-2015 11 62988 23177 63.2 0.153
2 14-02-2015 12 63105 21506.4 65.9 0.160
3 15-02-2015 13 62786 21387 65.9 0.159
4 16-02-2015 14 62355 22517 63.9 0.153
5 Continuous 17-02-2015 15 61922 21698.3 65.0 0.154
6 Flow 18-02-2015 16 61572 23500 61.8 0.146
7 19-02-2015 17 61256 24122 60.6 0.143
8 20-02-2015 18 60625 19546 67.8 0.158
9 21-02-2015 19 60152 20136 66.5 0.154
10 22-02-2015 20 59956 20257 66.2 0.152
COD removal percentage also increases with time of operation and is in the range of 4.7
% to 67.8% and the maximum efficiency of 67.8% is obtained which can be expressed
in graphs as given below.
70.0
60.0
50.0
% CODRemoval
40.0
10.0
0.0
0 1 2 3 4 5 6
Day
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 57
Chapter 4
70.0
60.0
50.0
% COD Removal
40.0
30.0
20.0
10.0
0.0
0 2 4 6 8 10 12
Day
Continuous flow
70.0
60.0
50.0
%Cod Removal
40.0
30.0
20.0
10.0
0.0
10 12 14 16 18 20 22
Day
Continuous flow
Figure 4.6 %COD removal → Days
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 58
Chapter 4
Table 4.8 Results of BOD removal & Gas generation of 1st & 2nd recycle
Table 4.9 Results of BOD removal & Gas generation of 1st continuous system
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 59
Chapter 4
Table 4.10 Results of BOD removal & Gas generation of 2nd continuous system
BOD removal percentage also increases with time of operation and is in the range of 6.18
% to 71.99% and the maximum efficiency of 71.99% is obtained which can be expressed
in graphs as given below.
70
60
50
% BOD Removal
40
30 1st Recycle
2nd Recycle
20
10
0
0 1 2 3 4 5 6
Day
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 60
Chapter 4
70
60
50
% BOD Removal
40
30
20
10
0
0 2 4 6 8 10 12
Day
Continuous flow
70
60
50
% BOD Removal
40
30
20
10
0
10 12 14 16 18 20 22
Day
Continuous flow
Figure4.7%BODremoval → Days
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 61
Chapter 4
0.025
0.020
Gas generation
0.015
1st Recycle
0.010
2nd Recycle
0.005
0.000
0 1 2 3 4 5 6
Day
0.025
0.020
Gas Generation
0.015
0.010
0.005
0.000
0 2 4 6 8 10 12
Day
Continuous flow
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 62
Chapter 4
0.025
0.020
Gas Generation
0.015
0.010
0.005
0.000
10 12 14 16 18 20 22
Day
Continuous flow
Figure 4.8 m3 Gas generation → Days
4.3 Discussion
o For the treatment of pharmaceutical industry wastewater from its important
characteristics, the reactor was designed and modifications were carried out for
the reactor. Experimental results were evaluated as per Indian Standards &
APHA.
o In this result COD of the effluent was reduced to 19546 mg/L from 61405.3 mg/L
which is varying from 4.7% to 67.8% and BOD/COD ratio is 0.34 average.
Which shows the biodegradability of wastewater. The BOD of effluent is reduced
to 6735 mg/L from 20105.2 mg/L which has maximum reduction of 68.27%.
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 63
Chapter 4
o TSS & VSS of influent 164 mg/L and 136 mg/L are increasing to 2359 mg/l and
1958 mg/L respectively so it can be said that because of microorganisms present
in biomass there is degradation of organic material and generation of methane gas
which is measured by balloon practically and theoretically by the kg COD
removal. Gas generation varies at the rate of 0.002 m3/d to 0.024 m3/d at optimum
COD reduction.
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 64
Chapter 5
CHAPTER-5
CONCLUSION
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 65
Chapter 5
CONCLUSION
Based on the observations and the results obtained from this study, the following points
could be concluded:
o The COD was found to reduce ranging from 60.2 % to 67.8% i.e. an average of
64.4 % reduction.
o The BOD was found to reduce ranging from 60.84 % to 68.28% i.e. an average of
65 % reduction.
o Concentration of TSS and VSS increased from 164 mg/L and 136 mg/L to 2359
mg/L and 1958 mg/L respectively at the level of maximum COD removal. This
clearly indicates the degradation of organic waste.
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 66
Chapter 6
CHAPTER-6
FUTURE SCOPE OF
WORK
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 67
Chapter 6
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 68
REFERENCES
PAPERS
[2] Chen A., Wang Y., Li K., and Hongbo Z. , “Effects of increasing
organic loading rate on performance and microbial community shift of
an up-flow anaerobic sludge blanket reactor treating diluted
pharmaceutical wastewater”, Journal of Bioscience and
Bioengineering VOL. 118 No. 3, 284e288, (2014)
[5] Gasparikova E., Kapusta S., Bodik I.,Derco J. and Kratochvil J., “
Evaluation of Anaerobic-Aerobic Wastewater Treatment Plant
Operations”, Polish Journal of Environmental Studies Vol. 14, No. 1,
29-34(2005)
[9] Kashyap D.R. , Dadhich K.S. amd Sharma S.K. “Review paper on
Biomethanation under psychrophilic conditions: a review” ,
bioresource Technology 87, International Journal of Current
Engineering and Technology ISSN 2277 – 4106(2003)
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 69
[11] Kumar R. L. and Snehlata, “Pharmaceutical Waste Water Treatment –
Potential of UASB Reactor”, International Journal of Current
Engineering and Technology, ISSN 2277 – 4106(2013)
[16] Oktem Y., Orhan I., Sallis P., Tom D. and Kasapgil B., “Anaerobic
treatment of a chemical synthesis-based pharmaceutical wastewater in
a hybrid upflow anaerobic sludge blanket reactor”, Bioresource
Technology 99 ,1089–1096(2007)
[17] Oktem Y., Orhan I., Sallis P., Tom D. and Kasapgil B.,
“Determination of optimum operating conditions of an acidification
reactor treating a chemical synthesis-based pharmaceutical
wastewater”, Process Biochemistry 41 , 2258–2263(2006)
[20] Rana R. S., Prashant S , Vikash K., Rakesh S., Rajendra D. and
Sanjay G., “A review on characterization and bioremediation of
pharmaceutical industries’ wastewater: an Indian perspective”, Appl
Water Sci DOI 10.1007/s13201-014-0225-3(2014)
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 70
[21] Sreekanth D. ,Sivaramakrishna D. , Himabindu V and Anjaneyulu Y. ,
“Thermophilic treatment of bulk drug pharmaceutical industrial
wastewaters by using hybrid up flow anaerobic sludge blanket
reactor”, Bioresource Technology 100 ,2534–2539(2009)
[24] Tasneem A., Tauseef S.M. and Abbasi S.A. “Review paper on
Anaerobic digestion for global warming control and energy
generation”, Renewable and stainable Energy Reviews, SCIENCE
DIRECT(2012)
[26] UNDP 206 Green Energy from Waste Page no.- 6,7,8,
Biomethanation Projects for Urban and Industrial Wastes set up under
UNDP/GEF assisted Project on Development of High Rate
Biomethanation Processes as means of Reducing Greenhouse Gases
Emission, ministry of non - conventional energy sources government
of india (2006)
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 71
[28] Yasar A. and Tabinda A. B., “Anaerobic treatment of Industrial
Wastewater by UASB reactor Integrated with Chemical Oxidation
process: an Overview”, Polish Journal of Environmental
Studies(2010)
[30] Zhiqiang C., Hongcheng W., Zhaobo C., Nanqi R., Aijie W., Yue S.
and Xiaoming L., “Performance and model of a full-scale up-flow
anaerobic sludge blanket (UASB) to treat the pharmaceutical
wastewater containing 6-APA and amoxicillin”, Journal of Hazardous
Materials 185 ,905–913(2011)
BOOKS
[13] Metcalf & Eddy,” Waste Water Engineering Treatment and Reuse”,
fourth Edition, Tata McGraw-Hill.
[18] Pelczar MJ, Chan ECS & Krieg NR, “Microbiology”, Tata McGraw-
Hill.
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 72
APPENDIX I
ABBRIVATIONS
AN Ammonical Nitrogen
BPR Biological Phosphorus Removal
CASP Conventional Activated Sludge Process
COD Chemical Oxygen Demand
BOD Biochemical Oxygen Demand
UASB Up flow anaerobic sludge blanket reactor
CSTR Continuous Stirred Tank Reactor
MBBR Moving Bed Biological Reactor
MLSS Mixed Liquor Suspended Solids
N-BOD Nitrogenous Biochemical Oxygen Demand
PAO Phosphate Accumulating Organism
PST Primary Sedimentation Tank
SBR Sequential Batch Reactor
SST Secondary Sedimentation Tank
SVI Sludge Volume Index
TSS Total Suspended Solids
VSS Volatile Suspended Solid
TN Total Nitrogen
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 73
APPENDIX II
Paper Publication Certificate
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 74
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 75
APPENDIX III
Plagiarism Report
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 76
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 77
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 78
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 79
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 80
APPENDIX IV
List of Industrial Visits
Name of
Sr Date of
Firm/Org Address Expert Purpose of Visit
No. Visit
anization
To understand UASB
B/H GPCB Office,
Emami process used for the
GIDC, Near National
1 Personal 08-08-2014 Mr. Tarun degradation of the
Highway 8, Vapi -
Care Ayurvedic Industry
396191.
waste
To study the UASB
Pirana Wastewater
tratment given to the
Sewage Treatment Plant, Mr. Girdhar
2 26-07-2014 domestic waste at
Treatment pirana, Vasna, Ram
very large scale of
Plant Ahmedabad
106 MLD
understanding of
Plot No. 2413 various procees of
M/S
117–118, G.I.D.C., treatment given to the
Enviro Mr.A.M.Darji
3 Ankleshwar, 17-09-2014 mixture of different
Technolog Unit Head
Dist- Bharuch, industrial waste water
y ltd.
Gujarat–393002. at advance
techchnology
Near Anand To understand
Agriculture Anaerobic process
Vidya
4 University, Borsad 12-09-2014 used for the
Dairy
Chowkdi, Anand - degradation of the
388001 dairy waste
To familiar with
Jetur Mr. Mahesh various process of
Kankia Plot,
Dyeing & Vaja,Env.Eng dyeing industries and
Behind St Bus Stop,
Printing ineer nature and treatment
5 Jetpur, Rajkot – 07-10-2014
Associatio Mr.Pravin given to the
360370
n Gondaliya, wastewater of dyeing
Gujarat, India.
Plant Incharge and printing
industries,
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 81
APPENDIX V
DISSERTATION REVIEW CARD
Study of Biomethanation process for Pharmaceutical wastewater using UASB reactor Page 82